- Home
- KRG vs ITGR Comparison
KRG vs ITGR Comparison
Compare KRG & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRG
- ITGR
- Stock Information
- Founded
- KRG 1971
- ITGR 1970
- Country
- KRG United States
- ITGR United States
- Employees
- KRG N/A
- ITGR N/A
- Industry
- KRG Real Estate Investment Trusts
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- KRG Real Estate
- ITGR Health Care
- Exchange
- KRG Nasdaq
- ITGR Nasdaq
- Market Cap
- KRG 5.0B
- ITGR 4.2B
- IPO Year
- KRG 2004
- ITGR 2000
- Fundamental
- Price
- KRG $22.31
- ITGR $105.33
- Analyst Decision
- KRG Buy
- ITGR Strong Buy
- Analyst Count
- KRG 10
- ITGR 9
- Target Price
- KRG $26.20
- ITGR $141.78
- AVG Volume (30 Days)
- KRG 1.9M
- ITGR 463.5K
- Earning Date
- KRG 10-29-2025
- ITGR 10-23-2025
- Dividend Yield
- KRG 4.84%
- ITGR N/A
- EPS Growth
- KRG N/A
- ITGR N/A
- EPS
- KRG 0.79
- ITGR 2.31
- Revenue
- KRG $857,126,000.00
- ITGR $1,794,800,000.00
- Revenue This Year
- KRG $2.97
- ITGR $10.92
- Revenue Next Year
- KRG N/A
- ITGR $7.35
- P/E Ratio
- KRG $28.43
- ITGR $45.61
- Revenue Growth
- KRG 3.60
- ITGR 9.64
- 52 Week Low
- KRG $18.52
- ITGR $99.73
- 52 Week High
- KRG $28.24
- ITGR $146.36
- Technical
- Relative Strength Index (RSI)
- KRG 44.75
- ITGR 48.11
- Support Level
- KRG $21.87
- ITGR $100.86
- Resistance Level
- KRG $22.48
- ITGR $106.58
- Average True Range (ATR)
- KRG 0.32
- ITGR 2.06
- MACD
- KRG -0.02
- ITGR 0.45
- Stochastic Oscillator
- KRG 19.51
- ITGR 55.77
About KRG Kite Realty Group Trust
Kite Realty Group Trust specializes in owning, operating, acquiring, developing, and redeveloping high-quality open-air shopping centers and mixed-use assets. The company generates the majority of its revenue from contractual rents and reimbursement payments received from tenants.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.